ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 134

$425K Total Retail Price of All Prescriptions

Rank: 50 out of 134

258 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 258 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 258 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,957 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 348 348 1 1
OMEPRAZOLE 347 331 2 3
FUROSEMIDE 279 269 3 7
PRAVASTATIN SODIUM 261 245 4 20
ENALAPRIL MALEATE 247 245 5 80
AMLODIPINE BESYLATE 238 211 6 6
LOSARTAN POTASSIUM 217 214 7 11
POTASSIUM CHLORIDE 215 203 8 10
WARFARIN SODIUM 201 186 9 8
HYDROCODONE-ACETAMINOPHEN 200 146 S3 10 5
SIMVASTATIN 189 168 11 2
ALENDRONATE SODIUM 132 132 12 21
METOPROLOL SUCCINATE 128 128 13 16
ALLOPURINOL 123 123 14 25
ATORVASTATIN CALCIUM 122 121 15 18
DIGOXIN 105 93 16 31
GABAPENTIN 103 78 17 12
SPIRONOLACTONE 101 99 18 29
TRIAMTERENE-HCTZ 99 95 19 40
HYDROCHLOROTHIAZIDE 90 86 20 13
ZOLPIDEM TARTRATE 86 86 21 15
DILTIAZEM 24HR CD 85 85 22 76
CRESTOR 84 72 23 39
DONEPEZIL HCL 84 84 23 30
METHOCARBAMOL 82 63 R 25 196
PREDNISONE 80 73 26 28
TAMSULOSIN HCL 79 79 27 26
VENLAFAXINE HCL ER 78 78 28 61
METOPROLOL TARTRATE 78 55 28 17
LOVASTATIN 77 77 30 33
ISOSORBIDE MONONITRATE ER 77 77 30 64
CITALOPRAM HBR 71 59 32 14
LISINOPRIL 66 66 33 4
METFORMIN HCL 64 57 34 9
FENTANYL 61 41 S2 35 41
ACETAMINOPHEN-CODEINE 57 50 S3 36 143
MELOXICAM 56 46 37 35
TORSEMIDE 56 56 37 107
SYNTHROID 55 43 39 56
PANTOPRAZOLE SODIUM 54 54 40 57
SERTRALINE HCL 53 53 41 24
ADVAIR DISKUS 52 50 42 38
SINGULAIR 52 44 42 94
OXYCODONE HCL 52 39 S2 42 71
GLIPIZIDE 51 49 45 99
CIPROFLOXACIN HCL 50 47 46 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.